JUL 25, 2020 12:21 PM PDT

Neurofibromatosis and How It Affects Heart Health

WRITTEN BY: Jasper Cantrell

Genetic diseases are persistent and often cause minor issues that can develop into more prominent problems later. Take neurofibromatosis type one, a common genetic disorder where a “loss of function” mutation occurs in the DNA encoding the protein neurofibromin. This protein is a critical regulator in cellular proliferation, and its loss can lead to the development of certain cancers and cardiovascular diseases.

The link between neurofibromatosis and cancer development is well known, but its role in cardiovascular disease remains unclear. A team from the University of Magna Graecia in Italy investigated the impact of neurofibromatosis type one on cardiovascular health to identify if patients with this disease have a higher risk of cardiovascular disease.

The team first assessed the vascular health of twenty-two neurofibromatosis type one patients by examining the vascular structure. Tests showed that neurofibromatosis patients had minor differences compared to healthy patients. In particular, the carotid artery walls were thicker in neurofibromatosis patients. This restricts blood flow, which can create a higher risk of cardiovascular disease if there is a lapse in cardiac health.

The functional difference between the two groups was more pronounced but still relatively minor. Exercise and oxygen deprivation tests showed neurofibromatosis patients had weaker cardiac strength. Heart rate was also higher in patients with neurofibromatosis, but blood chemistry was similar to healthy controls.

Over-all, this study suggests that patients with neurofibromatosis type one have minor changes in cardiac and vascular abilities. These changes are independent of cardiovascular diseases and are present in all ages. Patients with this disease should consider consistently checking their cardiovascular health, as these small changes are manageable but may increase the risk of other cardiovascular diseases.

The group concludes, “...in patients with NF1, alterations of vascular and cardiac function and morphology appear very early, and can be detected and followed over time. These findings might have significant clinical relevance suggesting a careful cardiovascular risk evaluation in subjects with NF1.”

Sources: Nature Scientific Reports, HealthSketch

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
SEP 23, 2020
Cannabis Sciences
Hemp Seeds May Reduce Heart Disease Risk
SEP 23, 2020
Hemp Seeds May Reduce Heart Disease Risk
Heart disease is the leading cause of death around the world. And it seems that many methods to avoid it involve lifesty ...
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
DEC 08, 2020
Cardiology
Some Stroke Risk Disparities May be Linked to Heart Structure
DEC 08, 2020
Some Stroke Risk Disparities May be Linked to Heart Structure
Scientists have found that there are structural differences in the heart's left atrium in Black and white people, an ...
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
FEB 18, 2021
Cardiology
Ongoing Heart Problems in Discharged COVID-19 Patients
FEB 18, 2021
Ongoing Heart Problems in Discharged COVID-19 Patients
About 50 percent of patients that are discharged from the hospital after recovering from a severe case of COVID-19 who e ...
APR 27, 2021
Cardiology
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
APR 27, 2021
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
The heart is one of the most reliable parts of the body. It pumps day and night, delivering fresh oxygen and nutrients t ...
Loading Comments...